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Introduction
Streptomyces clavuligerus is an actinomycete well known for its abil-
ity to produce a variety of β-lactam antibiotics including cephamy-
cin C and structurally related β-lactam compounds, the clavams. 
The initial step in the biosynthesis of β-lactams is the non-ribo-
somal condensation of L-α-aminoadipate (L-α-AAA), L-cysteine 
and L-valine, to form the tripeptide α-aminoadipyl-cysteinyl-
valine.1 In actinomycetes, α-AAA is a catabolic product of L-lysine 
produced from the lysine branch of the aspartate pathway2 and as 
shown in Figure 1, its availability is critical regarding precursor 
flux from the aspartate pathway to β-lactam biosynthesis.3,4
Different gene organization and regulatory mechanisms con-
trolling the metabolic flux through the aspartate pathway have 
been identified in bacteria.5 The ask (encoding the aspartokinase; 
EC 2.7.2.4) and asd (aspartate semialdehyde dehydrogenase; 
EC 1.2.1.11) genes are clustered in an operon in mycobacteria, 
corynebacteria and bacilli6-9 as well as in Amycolatopsis10 and 
S. clavuligerus,11 but not in Streptomyces akiyoshiensis.12 The regu-
lation of the aspartate pathway involves the multiplicity of the 
aspartokinase, first enzyme of the pathway, in certain bacteria 
like Escherichia coli and bacilli.13,14 In other organisms, includ-
ing actinomycetes, only one aspartokinase has been described. It 
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is feedback-regulated by either lysine as in Amycolatopsis mediter-
ranei15 or by the concerted action of lysine and threonine as in 
S. clavuligerus and A. lactamdurans.10,16
The formation of L-homoserine from aspartate-β-semialdehyde 
(ASA) by the homoserine dehydrogenase (Hsd; EC 1.1.1.3) is 
the first step of the branch of the aspartate pathway leading to 
L-threonine, L-isoleucine and L-methionine. Recently, the hom 
gene coding for this enzyme was cloned and characterized from 
S. clavuligerus and a hom mutant of this organism was constructed 
by cassette mutagenesis. The disruption of hom resulted in a two-
fold increase in cephamycin C specific production in chemically 
defined medium.17 The present study is aimed at the expression 
of multiple copies of the homologous ask gene in the wild strain 
of S. clavuligerus NRRL3585 and its hom-disrupted mutant, and 
to determine the effects of ask amplification on cephamycin C 
production.
Results and Discussion
In this study, two different ask transformants were constructed, 
S. clavuligerus TB3585 and S. clavuligerus BA39, containing mul-
tiple copies of the ask gene in the wild-type strain and in the 
hom mutant S. clavuligerus AK39, respectively. In order to obtain 
In this study, the effect of homologous multiple copies of the ask gene, which encodes aspartokinase catalyzing the 
first step of the aspartate pathway, on cephamycin C biosynthesis in S. clavuligerus NRRL 3585 and its hom mutant was 
investigated. The intracellular pool levels of aspartate pathway amino acids accorded well with the Ask activity levels in 
TB3585 and AK39. When compared with the control strain carrying vector alone without any gene insert, amplification 
of the ask gene in the wild strain resulted in a maximum of 3.1- and 3.3-fold increase in specific, 1.7- and 1.9-fold increase 
in volumetric cephamycin C production when grown in trypticase soy broth (TSB) and a modified chemically defined 
medium (mCDM), respectively. However, expression of multicopy ask gene in a hom-deleted background significantly 
decreased cephamycin C yields when the cells were grown in either TSB or mCDM, most probably due to physiological 
disturbance resulting from enzyme overexpression and high copy number plasmid burden in an auxotrophic host, 
respectively.
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carbon source not utilized by S. clavuligerus, but producing an 
homogeneous and disperse growth, and by increasing two-fold 
the L-asparagine concentration, since this amino acid is used as 
carbon and nitrogen source by S. clavuligerus. In this modified 
medium (mCDM), growth (Fig. 3A) and cephamycin C titers 
of the strains were lower than those in complex TSB medium, 
i.e., maximum cephamycin specific production by TB3585 was 
1,890 µg mg-1 in TSB while it was 1,581 µg mg-1 in mCDM. 
Nevertheless, the antibiotic level of TB3585 relative to its con-
trol TBV was higher in mCDM with 3.3- and 1.9-fold increase 
of specific and volumetric production at 72 h, respectively 
(Fig. 3B and C). As expected, the beneficial effect of hom-dis-
ruption in the AK39 strain was more pronounced in mCDM 
than in complex TSB (1.8-fold versus 1.3-fold increase in spe-
cific production). However the antibiotic levels of the BAV and 
BA39 strains in mCDM medium were very low and of almost 
equal level, suggesting an adverse effect of the plasmid itself as 
well as the multiple copies of ask. It was shown earlier that meta-
bolic changes which occur when cloned genes are expressed in 
auıxotrophic yeast strains may well arise from peculiarities of 
such hosts rather than the activity of the cloned proteins, hence 
avoidance of such auxotrophic host systems was strongly recom-
mended.22 Pleiotropic depression of antibiotic titers in auxotro-
phic mutants of streptomyces were also mentioned.23 Our results 
supported these warnings.
Expression of the multicopy ask gene in both strains was veri-
fied in aspartokinase assays on crude cell extracts of each strain 
grown in mCDM. Althought no noticeable differences were 
found at 24 h of fermentation, aspartokinase specific activities of 
the TB3585 and BA39 strains were 25- and 1.8-fold higher than 
TBV and BAV, respectively, at 48 h (Fig. 4).
The intracellular free amino acid pools in the wild type strain 
and in the recombinants (TB3585, AK39 and BA39) were next 
determined in cultures grown in mCDM in order to relate aspar-
tokinase overexpression with amino acid biosynthesis. Using 
asparagine as the sole carbon and nitrogen source, glycine was 
the predominating amino acid in the wild type strain followed 
by asparagine, glutamic acid and serine (data not shown). There 
were strong differences in the total pool content as well as in 
individual amino acids between strains. The glutamic acid and 
glycine contents of AK39 were 6 to 10 times higher compared 
to those of the wild type and TB3585 strains, and it always con-
tained much less asparagine than the other strains. The TB3585 
strain contained 2- to 4-fold more asparagine than the other 
strains. The highest intracellular amino acid content (2.2-fold) 
was found in AK39 (Fig. 5A). This strain synthesized apprecia-
ble amounts of lysine till 60 h (Fig. 5B) and extensively accumu-
lated externally added threonine (Fig. 5C). Thus its intracellular 
lysine plus threonine contents were almost always much higher 
than that of the other strains (Fig. 5D).
The intracellular pool levels of aspartate pathway amino 
acids accorded well with the Ask activity levels in TB3585 and 
AK39 in that the drastic increment of Ask specific activity at 
48 h was followed by a sharp increase in the intracellular pool 
levels of lysine and threonine till 72 h during which Ask activity 
gradually decreased. Cephamycin C levels also increased in this 
control strains the plasmid pIJ486 was introduced into wild-type 
and AK39 and the transformants were named TBV and BAV, 
respectively (Table 1).
Cephamycin C volumetric production by TB3585 was 
1.3-fold higher at 48th h and 1.7-fold higher at 96th h of growth as 
compared to the control TBV strain in TSB medium (Fig. 2B). 
This results in a specific production 2.2-times higher at 72 h 
and 3.1-times higher at 96 h fermentation, supporting a positive 
effect of additional copies of the ask gene on cephamycin C yields 
(Fig. 2C).
The expression on a multicopy plasmid of the homologous 
ask gene in the hom-disrupted BA39 strain was expected to 
lead to a further increase in cephamycin C levels due to: (1) the 
funnelling of the aspartate flow directly to L-lysine rather than 
being shared by the two branches (Fig. 1) and (2) a reduced/null 
concerted feedback inhibition of the aspartokinase due to lack of 
L-threonine biosynthesis. However, antibiotic production by the 
hom minus transformants carrying the amplified ask gene was 
delayed and the stimulatory effect on cephamycin production 
exerted by the ask overexpression in the wild type strain was not 
observed in the hom minus background (Fig. 2, right).
It was of interest to test if these results also occur in cells 
grown in defined medium. In our previous study, the growth of 
the AK39 strain was rather poor in chemically-defined medium, 
CDM, in spite of a two-fold increased specific level of cephamy-
cin C.17 Some inhibitory effects of glycerol on cephamycin C 
production18,19 as well as improvement of growth and cephamy-
cin C yields by L-asparagine20,21 have been previously reported. 
In the present study, the composition of CDM was submitted 
to several modifications to improve the growth of this strain 
and their transformants. The highest growth and antibiotic 
biosynthesis were obtained by replacing glycerol with sucrose, a 
Figure 1. The aspartate pathway in S. clavuligerus.
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shares common enzymes with the valine biosynthetic path-
way; cysteine and valine being the part of the antibiotic.27-30 If 
the aspartokinase regulation were the main responsible for a 
lack of further stimulation of cephamycin C production, the 
cloning of a feedback deregulated aspartokinase gene from a 
S-(2-aminoethyl)-L-cysteine resistant mutant might solve the 
problem.
Materials and Methods
Bacterial strains, plasmids, media and culture conditions. 
Bacterial strains and plasmids used are described in Table 1. 
E. coli cultures were grown in either Luria broth (LB; Q-Biogene, 
CA) or on Luria agar at 37°C. S. clavuligerus was maintained on 




O (20 µg ml-1). 
For isolation of plasmid DNA and protoplast preparation, seed 
interval, particularly in TB3585. Thus, the initial production of 
antibiotic within first 24 h of cultivation in both wild-type and 
recombinant strains seemed to be independent of Ask expression 
level and intracellular pools of amino acids.
Metabolic engineering has proven to be a rational alternative 
to classical strain improvement and today the β-lactam industry 
combines the two approaches. However, there are few studies 
aimed at enhancing cephamycin C yields by the manipulation of 
the aspartate pathway in S. clavuligerus. Malmberg et al. applied 
a metabolic engineering strategy which involved the introduc-
tion of an additional copy of the L-lysine ε-aminotransferase 
(lat) gene into the chromosome of S. clavuligerus.24 Its product 
(LAT) constitutes the first step in cephamycin C biosynthesis in 
which L-lysine coming from the aspartate pathway is eventually 
converted to α-AAA. This manipulation resulted in a 2- to 4-fold 
increase in specific cephamycin C production. Pérez-Llarena 
et al. demonstrated that amplification of the ccaR gene on a multi-
copy plasmid resulted in a two to three fold increase in cephamy-
cin and clavulanic acid yields.25 ccaR gene is located within the 
cephamycin gene cluster of S. clavuligerus and its product has a 
regulatory function in cephamycin C and clavulanic acid bio-
synthesis.25 This gene carries upstream of the promoter a 26 bp 
ARE sequence (AREccaR) for binding of a butyrolactone recep-
tor protein.26 When grown in starch-asparagine (SA) medium a 
mutant, S. clavuligerus ∆areB, unable to produce the butyrolac-
tone receptor protein, produced 1.4- to 3-fold more clavulanic 
acid, but the cephamycin C yield remained similar to that of the 
wild-type strain.
In the present study, we demonstrated that the amplification 
of the ask gene in S. clavuligerus TB3585 results in a significant 
increase in the volumetric and specific production of cephamy-
cin C, after 24 h growth in complex TSB medium. Although the 
growth and antibiotic formation were lower in defined medium, 
the pattern followed by the different strains was similar to that 
of cultures grown in complex medium.
The lack of the effect of ask amplification on cephamycin 
C production in a hom minus background might be due to 
multiple reasons. The pool of amino acids in this background, 
including those of lysine and threonine, was much higher than 
in other strains. This might affect the aspartokinase activity 
through a concerted feedback inhibition. Lysine + threonine 
pool increased 3.3-fold between 48 h and 72 h in mCDM 
(Fig. 5D) in this strain while its Ask activity decreased by 
14-fold (Fig. 4B). Mendelovitz and Aharonowitz reported 
that threonine at 10 mM concentration inhibited cephamycin 
production by 41% and different amino acids, as methionine 
or 2,6-diaminopimelate, affected the antibiotic production by 
inhibition of different enzymes of the pathway.16 Therefore, 
since the amino acid pool in the hom minus strain is higher, 
the aspartokinase, as well as other enzymes of the aspartate 
pathway leading to α-aminoadipic acid formation might 
be subjected to different types of regulation in this strain. 
Besides α-aminoadipic acid formation, aspartate pathway 
provides the methyl group (via S-adenosyl-L-methionine) and 
sulfur atom (transsulfuration) to cephamycin C as contrib-
uted by methionine, involves cysteine as an intermediate plus 
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defined medium (mCDM) which was prepared as 
in Malmberg et al.24 with some modifications; the 
amount of L-asparagine (Sigma) was increased from 
2 g l-1 to 4 g l-1 and 10 g l-1 glycerol was replaced with 
25 g l-1 sucrose (Merck). mCDM was supplemented 
with L-methionine (Sigma) and L-threonine (50 
mg l-1 each; Sigma) for growth of S. clavuligerus 
AK39, S. clavuligerus BA39 and S. clavuligerus BAV. 
Seed cultures were grown in 50 ml of TSB until 
mid-log phase and centrifuged at 3,200 rpm for 10 
min at 4°C. The pellets were washed with TSB or 
mCDM and resuspended in 50 ml of fresh media. 
The cultures were grown in duplicate flasks at 28°C 
at 220 rpm for 120 h.
DNA manipulations. Plasmid DNA was iso-
lated using Qiagen Plasmid Midi kits (Qiagen, 
Germany). DNA fragments were isolated from 
agarose gels using Qiagen Quickgel extraction kits. 
Restriction enzyme digestion of DNA was carried 
out according to suppliers’ recommendations. PCR 
products which were used in construction of recom-
binant plasmids were cloned in vector pGEM-T 
(Promega, WI) prior to transfer into the desired 
plasmid. Transformation of E. coli strains was per-
formed by standard procedures.33 E. coli plasmids 
that were used in the construction of recombinant 
S. clavuligerus plasmids were propagated in E. coli 
ET12567 to avoid restriction barriers.
Cloning of S. clavuligerus ask gene into pIJ486. 
Two oligonucleotide primers, 5'-TTC TAG AGT 
TCG TCC GGC TGC CGG T-3' and 5'-GGA TAT 
CCT ACC GCC CAC TTC CCG C-3', were used 
to generate a 1,506 bp DNA product comprising ask 
from the S. clavuligerus ask-asd operon.11 The PCR 
amplification was as follows: 95°C (10 min) and 
30 cycles of 95°C (1 min), 63°C (1 min) and 72°C 
(2 min). The amplified DNA was cloned into 
pGEM-T, released using XbaI and EcoRV and 
inserted into XbaI-EcoRV digested pBluescript II KS 
(Stratagene, Germany) to generate pTBKS. pTBKS 
was then digested with XbaI and HindIII and the 
resulting ask gene was inserted into XbaI-HindIII 
digested pIJ486 to create pTB486.
Transformation of S. clavuligerus. S. clavuligerus transfor-
mations were performed via PEG mediated protoplast transfor-
mation according to Kieser et al.31 with slight modifications. 
Transformants were regenerated on R2YE medium at 26°C for 
48 h and then each plate was overlaid with thiostrepton contain-
ing 2.5 ml soft nutrient agar.
Measurement of aspartokinase (Ask) activity. Aspartokinase 
(Ask) activity was measured in triplicates according to the pro-
cedure of Follettie et al.34 by determining the rate of formation 
of aspartyl-hydroxamate. Background activity was measured in 
the absence of aspartate. Ask specific activity was measured as 
nanomoles of aspartyl-hydroxamate formed per milligram pro-
tein per min.
culture media containing trypticase soy broth (TSB, Oxoid, 
UK) supplemented with 0.5% (w/v) maltose (Merck, Germany) 
was inoculated with spore stocks of S. clavuligerus and incu-
bated at 28°C on a rotary shaker (220 rpm) in baffled flasks for 
48–60 h. Five ml of this seed culture were inoculated into 50 
ml of 2:3 (v/v) mixture of TSB and yeast extract-malt extract 
medium (YEME,31) supplemented with 0.3% (v/v) glycine 
(Merck) and 3 mM MgCl
2
 and incubated at 28°C for 24 h. In 
the case of plasmid containing cultures, ampicillin (100 µg ml-1 
for E. coli, Sigma), or thiostrepton (50 µg ml-1 for S. clavuligerus, 
Sigma) was added to the medium. For antibiotic selection, 
Streptomyces colonies were plated on trypticase soy agar (TSA) 
supplemented with 8 µg ml-1 thiostrepton. For cephamycin C 
assay, the cultures were grown in TSB or a modified chemically 
Figure 2. Growth (A), volumetric (B) and specific (C) cephamycin C production of S. 
clavuligerus NRRL 3585 (open circles), TB3585 (open squares), TBV (open triangles), 
AK39 (closed circles), BA39 (closed squares), BAV (closed triangles) grown in TSB me-
dium. The experiment was performed in duplicate flasks and triplicate samples were 
assayed from each flask.
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Bioassay of β-lactam antibiotics. β-lactam antibiotic bio-
assays were conducted by agar plate diffusion with E. coli ESS 
3235 as indicator organism.18 Zones of inhibition were measured 
and cephamycin C concentrations in samples calculated using 
a standard curve constructed with cephalosporin C (Sigma). 
Cephamycin concentration is calculated as cephalosporin C 
equivalents.
Determination of intracellular free amino acid concentra-
tions. Cells were grown in mCDM, and samples were collected 
at intervals during cultivation. Intracellular free amino acids 
were extracted as described by Yılmaz et al.17 Following auto-
mated pre-column derivatization with o-phthaladehyde (OPA), 
amino acid analysis was performed by conventional reverse-phase 
Growth determination. Cultural growth was determined by 
DNA quantification with diphenylamine method adapted from 
Burton.35 2 ml of cell culture was centrifuged at 13,200 rpm for 
10 min and the pellet was resuspended in 1 ml of 0.85% NaCl 
(Merck). 0.5 ml of 1 N perchloric acid (Merck) was added into 0.5 
ml of sample and incubated at 70°C for 20 min. To the mixture 
was added 1 ml of diphenylamine (Sigma) reagent and incubated 
overnight at 30°C. The mixture was centrifuged at 13,200 rpm for 
10 min and the absorption was measured at 600 nm. DNA con-
centrations were calculated from a regression equation obtained by 
assaying known concentrations of herring sperm DNA (Sigma). 
The values were multiplied by a factor of four and the DNA con-
centration was defined as µg of DNA per ml of culture.
Figure 3. Growth (A), volumetric (B) and specific (C) cephamycin C production of S. clavuligerus NRRL 3585 (open circles), TB3585 (open squares), TBV 
(open triangles), AK39 (closed circles), BA39 (closed squares), BAV (closed triangles) grown in defined mCDM medium. The experiment was performed 
in duplicate flasks and triplicate samples were analyzed from each flask.
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Figure 4. Specific Ask activities of (A) S. clavuligerus NRRL 3585 (white), TBV (grey), TB3585 (black) and (B) AK39 (white), BAV (grey), BA39 (black) grown 
in defined mCDM medium. The experiment was performed in duplicate flasks and triplicate samples were analyzed from each flask.
Figure 5. Total amounts of the intracellular free amino acids (A) and intracellular pool of lysine (B), threonine (C) and lysine plus threonine (D) in S. 
clavuligerus NRRL 3585 (open circles), TB3585 (open squares), AK39 (closed circles), BA39 (closed squares) grown in defined mCDM medium. The experi-
ment was performed in duplicate flasks and triplicate samples were analyzed from each flask.
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